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Abstract. Pilonidal disease is a common and well-recognized medical condition. It affects people in reproductive age, 
especially men and in combination with in-patient and outpatient treatment and absence from work it causes a considerable 
socioeconomic loss. This fact led to a renewed interest in understanding of the disease and search for the ideal method of 
treatment. The purpose of this review was to provide update on therapeutic options for patients with pilonidal disease. In 
case of chronic or recurrent pilonidal disease various treatment options exist, addressing different measures of surgical 
outcome. Like for many conditions, there is increase in the use of minimally invasive techniques in the treatment, which 
could be alternative to surgical excisions for pilonidal disease. Procedures for treatment of pilonidal disease can be divided 
in two large groups: minimally invasive treatment and excisional procedures. Although various treatment options exist 
nowadays, surgery is still preferred as definitive treatment. The optimal closure of the wound following an excision is still 
under debate since outcome measures depend mostly on type of closure selected. Most of the procedures fail to achieve the 
goals altogether. The final decision on treatment should be made based on surgeon and the patient’ preference. 
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Introduction

 
Pilonidal disease is a common and well-recognized 
medical condition. Its first description dates back to 
1833, when Herbert Mayo described a sinus containing 
hair. In 1880, Hodge suggested the term “pilonidal”, 
from the Latin word pilus, which means hair and nidus 
for nest (Fig. 1). Pilonidal disease (PD) affects people in 
reproductive age, especially men, which is in combina-
tion with in-patient and outpatient treatment and ab-
sence from work a considerable socioeconomic loss. 
This fact led to a renewed interest in understanding the 
disease and search for an ideal method of treatment [1].  
The purpose of this review is to provide update on 
therapeutic options for patients with PD. Authors 
searched Medline using PubMed for articles in English 
language not older than ten years using search terms 
“pilonidal disease”, “pilonidal sinus”, “excision of pi-
lonidal disease”, “pilonidal disease guidelines”. Older 
publications were hand searched and selected if consid-
ered relevant for the subject.  
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Fig. 1 Nest of piles (pilonidal disease) 
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Incidence and risk factors 
Incidence of pilonidal disease differs between continents. 
It‟s rare in Asia and Africa and high in Caucasians, 
highest recorded in Mediterranean area. Its incidence is 
rising due to reasons that are yet to be established. For 
example in Germany in 2012 there was increase from 29 
patients per 100.000 earlier recorded to 48 per 100.000. It 
is probably due to sedentary life style, since even in 
population with small incidence rate, like Japan, pilonidal 
disease is seen more often in people with jobs requiring 
long sitting hours [2,3]  
Pilonidal disease is more common in dark-skinned 
and dark-haired persons with excess body hair. Obesity 
is also recorded as risk factor [3,4]. Apart from these, 
male gender, poor body hygiene and excessive sweating 
are also described as risk factors. In the lack of pro-
spective studies Harlak et al. published a prospective 
case control study in 2010 conducted among 587 pa-
tients and 2,780 healthy control subjects investigating 
risk factors for development of PD. According to their 
findings there are three most predictive risk factors: 
body hair rate, bathing habbits and sitting time. Using 
logistic regression analysis there was 219-fold higher 
risk for hairy people who shower or bathe two or less 
times per week and sit more than six hours per day 
compared with hairless people who shower or bathe 
three or more times per week and sit less than six hours 
a day to develop disease. The adjusted risk of PD was 
6.33-fold greater for those who bathe two or less times 
per week than the risk for those people who take three 
or more baths per week, while the adjusted risk was 4.3-
fold higher for individuals who were sitting more than 
six hours in a day. BMI was found to be a less important 
risk factor, but results might be different in investigation 
of community-based population, since this study in-
cluded only active soldiers [5]. Later study also found 
irregular bathing as a risk factor for PD [4]. 
From its first description to the middle of 20th cen-
tury PD is thought to be congenital. Probably the most 
cited theory of PD development is one by Gorge. E. 
Karydakis from General Army Hospital in Greece, who 
published his work in Lancet in 1973, after he examined 
4670 previously operated Army candidates (with nearly 
50% recurrence rate), and operated on 1687 patients 
using his new method [6]. He developed further the the-
ory on hair insertions, which was first mentioned by 
Patey and Scarff in 1946. According to Karydakis PD is 
acquired and causative process that can be defined pre-
cisely using equation. The equation consists of three 
main factors which play a role in the hair insertion pro-
cess: Hair (H) x Force (F) x Vulnerability (V). It can be 
used to calculate the possibility of PD. If these three 
main factors occur, then hair insertion and pilonidal 
sinus result. It is possible to list many secondary factors 
which together make up the three main factors, such as 
for example for H: number of loose hair, type or shape 
of hare, or for F: depth of natal cleft and friction; for V: 
wide pores, presence of wounds or scars at the natal 
cleft. All these factors not only explain all the known 
variations of the incidence PD, and the variation of its 
incidence in the same population over time, but also 
provide an answer to presence or absence of disease in 
some cases, for example, the presence of pilonidal sinus 
in some „hairless‟ individuals, and its absence in others 
with hirsutism [7].  
Experimental case matched study by Doll et al., 
compared mechanical strength of hair in occipital, lum-
bar, and intergluteal region and its relation to develop-
ment of PD. The study has shown that vertical strength 
of occipital, lumbar, and intergluteal hair (along dorsal 
crest) from patients suffering from pilonidal disease was 
significantly greater than hair from their matched pairs. 
Cut hair fragments from occipital region were found in 
pilonidal nest which suggests that disease is related to 
this particular region as source. In concordance to their 
study authors are suggesting reduction in production of 
hair fragments in occipital (for example by shaving), 
removing cut hair along dorsal crest, reducing contact 
with hair within intergluteal fold such as with promptly 
showers after a hair cut in persons at risk [8].  
Diagnosis and management 
The diagnosis of PD is mostly established based on pa-
tient‟s history and clinical findings. Clinical finding are 
almost always visible characteristic pits in the interglu-
teal cleft, sometimes with hair extruding from their 
openings (Fig. 2). In recurrent disease or in chronic 
phase, sinus tract opening is visible (Fig. 3). According 
to Task force of the American Society of Colon and 
Rectal Surgeons from 2013, presacral mass should be 
 
Fig. 2 Pits in intergluteal cleft 
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ruled out by digitorectal examination. Laboratory or 
imaging methods are not routinely used. It is important 
to distinguish PD from other conditions, such as peria-
nal fistula, Crohn‟ disease or some infectious diseases 
(TBC, Syphilis or actinomycosis) [9]. Pilonidal disease 
can sometimes be mistaken for solitary hidradenitis 
suppurativa but unlike PD, hidradenitis affects more 
women than man. Their sonographic characteristics are 
also similar and accordingly PD might be a variant of 
localized form of hidradenitis suppurativa. Their histol-
ogy is somewhat different, although histology finding 
cannot be always helpful in distinguishing PD from hid-
radenitis suppurativa [10]. 
Pilonidal disease can initially present as sacrococ-
cygeal abscess. It is widely accepted that in this case 
incision and drainage are preferred method of treatment. 
Disease recurrence following this episode is reported to 
be 20% after 20 years, and there is no justification for 
wide excisions in this case since 80% of patients will be 
over treated and with substantial morbidity and doubled 
average time to return to work [11]. According to retro-
spective study from Australia on 134 patients with lat-
eral longitudinal incision and 74 with midline incision, 
abscess with incision away from midline healed faster 
(p=0.02). Although admitting limitations of the study 
they concluded that pilonidal abscess should be drained 
away from the midline [12]. 
In case of chronic or recurrent disease various treat-
ment options exist, addressing different measures of 
surgical outcome. 
Like for many conditions there is increase in the use 
of minimally-invasive techniques in the treatment of 
PD, which could be alternative to surgical excisions for 
PD. Nowadays the treatment options could be divided in 
two large groups: minimally-invasive treatment or exci-
sional procedures.  
Minimally-invasive treatment of PD 
Pit picking procedure was first described in 1965 by 
Lord and Millar who excised in local anesthesia affected 
pits using small elliptical excision, removed the hair and 
showed resolution in 32 out of 33 patients. Bascom was 
also one of the surgeons who recognized the importance 
of pit excision with addition of lateral incision for deb-
ridement of the sinus cavity [13]. In a recent study with 
adolescent patients, disease resolved in 92% of cases 
using this technique, although follow up period was 
limited to 5 months. According to authors advantages of 
this procedure is ease of performance in outpatient set-
ting, it is well tolerated, requires minimal postoperative 
care and offers rapid recovery [14]. Reported recurrence 
rates with this procedure range from 1020% [15].  
Fibrin glue is often used in surgical practice. Its use 
in treatment of PD started in 2000. In 2018, results from 
single center study were published on 146 patients with 
PD of which 13% previously already had some kind of 
treatment. Procedures were done as one day surgery 
under general anesthesia (apart from one patient). After 
insertion of blunt probe for tract identification, sinuses 
were curetted and then flush with saline solution. Af-
terward the fibrin glue was inserted. No additional 
dressings were needed. Median operating time was 9 
min. There were 27% of recurrences after the first glue 
application. Twenty four patients with recurrence de-
cided for repeated treatment. Cumulative healing after 2 
rounds was 96.9%. This procedure does not require 
technical equipment and can be easily thought and per-
formed [16]. According to Cohran review current evi-
dence is uncertain regarding the benefits associated with 
fibrin glue as monotherapy in PD or as adjunct to sur-
gery. There is small number of low quality trials on the 
subject. RCT are needed to enroll larger number of pa-
tients measuring clinically relevant outcomes. 
Phenol is also used in minimally- invasive treatment 
for many decades. It is a necrotizing material which 
causes burns on mucosa and skin. The preferred phenol 
is liquid (pure or 80%) or crystallized which turns into 
liquid form quickly at body temperature. Application 
tool is different according to the entrance technique. In 
the incision techniques, usually cotton swab with phenol 
is moved in the cavity. In the techniques without inci-
sion, one of the sinus openings are cannulated with a 
venous catheter or a blunt-ended metal trocar and phe-
nol is injected into the sinus without pressure and left 
for 13 minutes. The injected volume of phenol is mean 
1.7±1.9 ml. The sinus is then washed out with normal 
saline to prevent phenol leakage. The patients treated 
under local anesthesia are able to leave the hospital im-
mediately after the procedure. Recurrence is regarded as 
occurrence of the same complaints after asymptomatic 
period and a second cause of treatment failure. Most 
studies mentioned that repeated applications were done 
if necessary (continuation of purulent discharge). Time 
interval between the repeated applications was variable 
among the studies (from 1–6 weeks). Wound healed 
long but there was immediate return to activities. Satis-
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factory results with no evidence of recurrence or pro-
longed discharge were obtained in 60–100% of the pa-
tients [18]. Up to date there is only one RCT trail that 
compared effect of phenol injection with excision and 
open healing. Study included 140 patients equally dis-
tributed in both arms. Time to complete wound healing 
(16.2 ± 8.7 versus 40.1 ± 9.7 days) was significantly in 
favor of the phenol injection group (p<0.001). The me-
dian operation time was significantly shorter (p< 0.001). 
Pain score after surgery as well as painkiller intake were 
also in favor of phenol group. At the mean follow-up of 
39.2 ± 9.0 months no difference was seen in the recur-
rence rate between the two arms. Authors of the study 
concluded that phenol injection is as effective as the 
excision with open healing in the PD treatment [19]. 
Phenol therapy can be combined with other methods of 
treatment such as video-assisted diathermy ablation of 
the sinus cavity, with achievement of good results after 
22 months of follow up in terms of fast wound healing 
and low recurrence [20]. 
 Endoscopic treatment of PD implies ablation of si-
nus tract using video assisted guidance. In the literature 
it is found under the name of EPSiT (endoscopic piloni-
dal sinus treatment) or VAAPS (video-assisted ablation 
of pilonidal sinus). View through the endoscope allows 
identification of lateral tracts [21]. A recent systematic 
review and meta-analysis of endoscopic treatment of PD 
with nine studies and 497 patients was published. The 
mean operating time was 34.7 ± 17.7 min. Procedure 
was performed as day-case surgery in all. Seven studies 
reported the pain VAS (measured from 010) within the 
first week after the procedure, the mean VAS was 1.35 
± 0.8 (range, 0.5–2), while 36 (8.6%) patients required 
intravenous analgesics in the first postoperative day. 
Failure of the technique was recorded in 40 (8.04%) 
patients, 20 (4.02%) had persistent (non-healing) piloni-
dal sinus, and 20 (4.02%) developed recurrence of SPD 
after complete initial healing of the primary wound. The 
weighted mean failure rate of the technique was 6.3% 
(95% CI 3.6–9.1). Failure of the technique was man-
aged with redo of endoscopic treatment in 24 patients. 
Complication rate across the study ranged between 0 
and 11.1%. Complications included hematoma, infec-
tion, persistent discharge, and failure of healing. The 
mean weighted complication rate was 1.1% (95% CI 
0.3–2.4). The mean time to complete healing after the 
procedure was 32.9 ± 23 days. The mean time to return 
to work and normal activities was 2.9 ± 1.8 day. Ninety 
five percent were completely satisfied with the proce-
dure. Authors conclude that endoscopic treatment of PD 
is a novel and promising method whose main advantage 
over conventional surgery are mild postoperative pain, 
quick healing, and short time to return to work and daily 
activities. The long-term outcome of the procedure is 
still unclear and longer follow-up is needed [22]. 
After good initial results Georgiou published data on 
Pilonidal disease Laser Treatment (PiLaT) in patients 
with primary disease. Patients with disease recurrence 
were excluded. In local anesthesia and in prone position 
after debridement and flushing with saline solution of 
pits and sinus tracts, a 12 mm metallic probe was in-
serted into sinus. Energy was deliver trough a tip of the 
probe in circumferential manner in order to shrink and 
obliterate tract. Primary end point of the study was 
healing at 8 weeks, and preservation of these results up 
to 12 months. After one year out of 60 patients enrolled, 
overall success rate was 92%. All of patients who failed 
the first time except for one, agreed to undergo again 
PiLaT procedure. With this results success rate reached 
98% [23]. Similar results were earlier published in Bel-
gium with reported recurrence of 2.9% and success rate 
of 87.5% [24]. Both studies conclude that it is safe, 
highly effective, almost painless and easy to learn and to 
perform and should be offered to all patients. Drawback 
of this procedure is its cost (around 600 euro), which 
could be balanced with earlier return to work. These 
studies included small number of patients (60 and 40), 
and promising results should be evaluated through 
longer follow up and in RCT.  
Excisional procedures 
Open excision is the approach most frequently imple-
mented globally. Complete resection of the sinus is fol-
lowed by thorough curettage of the cavity. The wound is 
left to heal by secondary intention or wound edges can be 
marsupialized. The disadvantage of this procedure is long 
healing time with delayed return to work. Reported recur-
rence rates vary greatly from 2% to 35% [25]. Meta-anal-
ysis on 26 RCT and 2530 patients compared open wound 
to primary closure. Wound with primary closure did heal 
faster. On the other hand recurrence rates were lower for 
open wounds (RR 0.60, 95% CI 0.42 to 0.87). This meta-
analysis did not show difference in rates of SSI between 
two groups [26]. Randomized control trial compared Lim-
berg flap procedure to secondary wound healing following 
excision (Fig. 4). Limber flap procedure took longer 60 
(3080)  vs. 30 (1075) minutes (p < 0.001) and had higher 
 
Fig. 4 Limberg flap procedure 
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complication rate (49% vs. 12%, p < 0.001). Limberg flap 
procedure failed to show advantage over open wound 
mainly due to high complication rate [27]. One of the con-
clusions of the previously mentioned meta-analysis was 
that there was advantage of off-midline over midline 
wound closure, although in some studies midline suturing 
is of no importance if it is done in tension free manner [26]. 
Sevinc et al., conducted a RCT comparing midline and off-
midline closure. Patients with primary PD were randomly 
assigned into 3 groups (two different flap procedures and 
tension free primary closure), 50 each. Main outcome 
measures were complications and recurrence. The groups 
were similar in terms of infection rate and development of 
seroma. The mean painless sitting time was significantly 
shorter in primary group. The median follow up time of the 
study was 24.2 months and the recurrence rates were simi-
lar (p=0.876). According to the authors of the study release 
of subcutaneous tissue enabling tension free suture line 
eased wound healing [28].  
Off-midline procedures, such as Karydakis flap or 
Limberg rotation flap are oriented towards flattening of 
the natal cleft. Low recurrence rate after originally 
described Karydakis procedure, is due to simple objec-
tive "no raphe, no wound and scar at the depth". The 
intact skin put at the depth seems not to inherit the vul-
nerability of the raphe. The natural depth of the inter-
gluteal fold, the raphe, is invaded by the hair and scar in 
the midline can easily become new entry point [6].  
Meta-analysis from 2018 tried to give an answer to 
the question, which off-midline procedure is most ap-
propriate. Eight studies involving 1121 patients were 
included. Patients were operated with either Karydakis 
flap (KF) or using Limber flap reconstruction. All of the 
studies were conducted between year 2004 and 2013. 
Long time follow up rate ranged from mean 15.5 to 33.3 
months. In some studies modified Limberg flap technique 
was used, by performing excision with the lower border 
of the rhomboid 2 cm lateral from to the cleft. In 
subgroup analysis there was no difference between 
modified Limberg flap (LF) and conventional LF in all 
outcome measures including recurrence, except for 
postoperative rate of seroma. No statistically significant 
difference in recurrence rate between LF and KF was 
noted (OR=1.07; 95%CI[0.59-1.92]; p=0.83. There was 
significant difference in terms of seroma favoring LF 
[OR=2.03; 95%CI[1.15-3.95]; p=0.01). There were no 
differences in wound rupture nor in wound infection rate. 
Data on overall morbidity could not be pooled due to 
high statistical heterogeneity. In two studies statistically 
significant difference were found favoring LF, while in 
remaining six morbidity was comparable. KF required 
shorter operating time in all studies. Most of the studies 
report similar time to return to work in both arms [29].  
 The recurrence rate is the most important variable for 
the comparative assessment of different treatment 
modalities, although in most publications recurrence is not 
defined. In some cases surgical treatment is followed by a 
non-healing wound that sometimes requires second 
operation. From the academic perspective, absence of 
wound healing is not correctly designated as a recurrence, 
but from the patient‟s point of view, the only relevant fact 
is that repeat surgery must be done. For that reason the 
term “treatment failure” would be preferable [15].  
When it comes to long term patient satisfaction re-
currence is most important. Study on 583 male patients 
from military cohort with long follow up (7-22 years) 
investigated patient satisfaction with surgical treatment in 
terms of in-hospital time, outpatient treatment, pain, 
aesthetic impression and long term recurrence rate. Ac-
cording to the results patients are dissatisfied with the 
results of any surgical technique, if they experience re-
current disease. Pain during wound treatment and cosmesis 
has no influence on patient satisfaction in the long term, as 
long as they are recurrence-free over the next 20 years [2].  
Recurrence rate following surgery for PD depend on 
follow-up time. This was pointed out in the meta-analysis 
and merge analysis from 2018, on combined RCT/non-
RCT studies with 89,583 patients available from 1833 to 
2017. This dependence, i.e. the steepness of increase of 
recurrence with longer follow-up times, is specific to a 
surgical procedure. According to these data primary 
midline closure should be abandoned, while older 
therapies (such as marsupialization) may be reconsidered. 
Flap procedures (Karydakis, Bascom, Limberg) and 
asymmetric procedures are superior, as proven by RCT 
and combined RCT/non-RCT trials. Follow-up of PSD 
patients should always be planned long term, i.e., five or 
ten years for reliable conclusion [30]. 
Currently there are three guidelines for the treatment of 
PD available, all made by relevant surgical societies, from 
Italy, USA and Germany [31-33]. In Germany despite the 
increasing number of novel procedures most surgeons still 
prefer traditional methods. The level of evidence on most 
topics is moderate or low, while most of RCT are lacking a 
power calculation and do not describe allocation conceal-
ing. Most trials have been performed in Middle East and 
Southern Europe, which questions the applicability of the 
obtained results [31]. Patient needs to be adequately in-
formed about all aspects of treatment, from possible com-
plications, cosmetic effects, postoperative course, to risk 
for recurrence [32]. Clinical Practice Guidelines Commit-
tee of the American Society of Colon and Rectal Surgeons 
published the latest guideline for PD treatment in 2019 
[33]. Based on low quality evidence there is weak recom-
mendation for elimination of hair from the intergluteal cleft 
and surroundings in both, acute and chronic pilonidal dis-
ease, in the absence of abscess as a primary or adjunct 
treatment measure. Based on moderate quality evidence in 
patients with acute or chronic pilonidal disease without 
abscess, phenol application is an effective treatment that 
may result in rapid and durable healing (strong recommen-
dation). Fibrin glue may be effective as a primary or ad-
junctive treatment of PD (weak recommendation based on 
moderate-quality evidence). Patients who require surgery 
for chronic PD may undergo excision and primary repair 
(with consideration for off-midline closure), excision with 
healing by secondary intention, or excision with marsupi-
alization. Flap-based procedures may be performed, espe-
cially in the setting of complex and recurrent chronic PD 
when other techniques have failed (strong recommendation 
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based on moderate-quality evidence). Minimally invasive 
approaches to acute and chronic PD that use endoscopic or 
video assistance may be used but require specialized 
equipment and expertise (weak recommendation based on 
moderate-quality evidence). It is emphasized, that these 
guidelines should not be inclusive of all proper methods of 
care nor exclusive of other methods [33]. The final deci-
sion on treatment has to be individualized for every patient 
taking into consideration also surgeon experience and con-
fidence in performing different techniques [32,33]. 
Conclusion 
Although various treatment options exist nowadays 
surgery is still preferred as definitive treatment. The 
optimal closure of the wound following an excision is 
still under debate since outcome measures depend mostly 
on type of closure selected. Most of the procedures fail to 
achieve the goals altogether. The final decision should be 
made based on surgeon and patients‟ preference. 
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